JP2009514963A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009514963A5 JP2009514963A5 JP2008540128A JP2008540128A JP2009514963A5 JP 2009514963 A5 JP2009514963 A5 JP 2009514963A5 JP 2008540128 A JP2008540128 A JP 2008540128A JP 2008540128 A JP2008540128 A JP 2008540128A JP 2009514963 A5 JP2009514963 A5 JP 2009514963A5
- Authority
- JP
- Japan
- Prior art keywords
- rosacea
- pharmaceutical composition
- granulomatous
- azithromycin
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 201000004700 rosacea Diseases 0.000 claims description 13
- 238000011282 treatment Methods 0.000 claims description 7
- MQTOSJVFKKJCRP-BICOPXKESA-N azithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 MQTOSJVFKKJCRP-BICOPXKESA-N 0.000 claims description 5
- 229960004099 azithromycin Drugs 0.000 claims description 5
- 239000008194 pharmaceutical composition Substances 0.000 claims 6
- 229920000742 Cotton Polymers 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 230000009885 systemic effect Effects 0.000 claims 1
- 241001303601 Rosacea Species 0.000 description 7
- 239000003814 drug Substances 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US73484305P | 2005-11-09 | 2005-11-09 | |
| PCT/US2006/043339 WO2007086978A2 (en) | 2005-11-09 | 2006-11-08 | Azithromycin for treatment of granulomatous rosacea |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009514963A JP2009514963A (ja) | 2009-04-09 |
| JP2009514963A5 true JP2009514963A5 (https=) | 2009-11-19 |
Family
ID=38309684
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008540128A Pending JP2009514963A (ja) | 2005-11-09 | 2006-11-08 | 肉芽腫性酒さの治療ためのアジスロマイシン |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20070105788A1 (https=) |
| EP (1) | EP1945227A4 (https=) |
| JP (1) | JP2009514963A (https=) |
| CN (1) | CN101304750A (https=) |
| AU (1) | AU2006336612A1 (https=) |
| BR (1) | BRPI0617693A2 (https=) |
| CA (1) | CA2626551A1 (https=) |
| RU (1) | RU2008122964A (https=) |
| WO (1) | WO2007086978A2 (https=) |
| ZA (1) | ZA200804896B (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8124123B2 (en) * | 2007-09-05 | 2012-02-28 | Dow Pharmaceutical Sciences, Inc. | Controlled release azithromycin solid dosages forms |
| US8143227B2 (en) * | 2007-09-05 | 2012-03-27 | Dow Pharmaceutical Sciences, Inc. | Azithromycin for treatment of skin disorders |
| MX2010009493A (es) * | 2008-02-28 | 2010-12-20 | Rp Scherer Technologies Llc | Proceso para minimizar el polimorfismo. |
| WO2010006306A1 (en) * | 2008-07-10 | 2010-01-14 | Inspire Pharmaceuticals, Inc. | Method of treating blepharitis |
| WO2010085572A1 (en) * | 2009-01-23 | 2010-07-29 | Inspire Pharmaceuticals, Inc. | Method of treating dry eye disease with azithromycin |
| RU2425682C1 (ru) * | 2010-04-28 | 2011-08-10 | Федеральное государственное учреждение "Уральский научно-исследовательский институт дерматовенерологии и иммунопатологии Федерального агентства по высокотехнологичной медицинской помощи" (ФГУ "УрНИИДВиИ Росмедтехнологий") | Способ лечения акне средней степени тяжести |
| US20130274214A1 (en) * | 2010-12-29 | 2013-10-17 | Inspire Pharmaceuticals, Inc. | Method for treating blepharitis |
| JP5986632B2 (ja) | 2011-06-28 | 2016-09-06 | メディシス ファーマシューティカル コーポレイション | 高用量粘膜接着性メトロニダゾール水系ゲル製剤および細菌性膣炎を治療するためのそれらの使用 |
| WO2014100569A1 (en) * | 2012-12-20 | 2014-06-26 | Medicis Pharmaceutical Corporation | High dosage topical metronidazole gel formulations |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2446356C (en) * | 2001-05-09 | 2012-07-10 | The Regents Of The University Of Michigan | Use of compositions for treating rosacea |
-
2006
- 2006-11-08 BR BRPI0617693-3A patent/BRPI0617693A2/pt not_active IP Right Cessation
- 2006-11-08 RU RU2008122964/14A patent/RU2008122964A/ru not_active Application Discontinuation
- 2006-11-08 WO PCT/US2006/043339 patent/WO2007086978A2/en not_active Ceased
- 2006-11-08 CA CA002626551A patent/CA2626551A1/en not_active Abandoned
- 2006-11-08 JP JP2008540128A patent/JP2009514963A/ja active Pending
- 2006-11-08 US US11/594,451 patent/US20070105788A1/en not_active Abandoned
- 2006-11-08 CN CNA2006800418105A patent/CN101304750A/zh active Pending
- 2006-11-08 EP EP06849873A patent/EP1945227A4/en not_active Withdrawn
- 2006-11-08 AU AU2006336612A patent/AU2006336612A1/en not_active Abandoned
-
2008
- 2008-06-05 ZA ZA200804896A patent/ZA200804896B/xx unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Iqbal et al. | Role of antifungal medicaments added to tissue conditioners: A systematic review | |
| JP2013505282A5 (https=) | ||
| EA200802012A1 (ru) | Фармацевтические препараты в форме раствора для дозирующих ингаляторов под давлением | |
| EP2248519A3 (en) | Non-mucoadhesive film dosage forms | |
| CA2683786C (en) | Use of tapentadol in the treatment of pain and with a reduced incidence of tapentadol-induced side-effects | |
| NZ604029A (en) | Methods of treating bladder cancer | |
| JP2015532296A5 (https=) | ||
| BR0308989A (pt) | Formulações de claritromicina com biodisponibilidade aperfeiçoada e processo de preparação das mesmas | |
| JP2009514963A5 (https=) | ||
| Işik et al. | Analgesic efficacy of prophylactic gabapentin and lornoxicam in preventing postendodontic pain | |
| WO2009022067A8 (fr) | Medicament pour traiter la maladie de parkinson | |
| Mercadante | Managing breakthrough pain | |
| WO2009022068A3 (fr) | Medicament pour traiter la maladie de parkinson | |
| Ruoff | OTC analgesics vs opioids for pain management. | |
| Kiran et al. | Efficacy and Safety of a combination of Paracetamol, Levocetirizine and Phenylepherine in the symptomatic treatment of Common Cold and Allergic Rhinitis: Phase IV Clinical Study | |
| CN103211982A (zh) | 一种治疗三叉神经痛的药物 | |
| Cazzola et al. | Onset of action of formoterol versus salmeterol via dry powder inhalers in moderate chronic obstructive pulmonary disease: a randomized, placebo-controlled, double-blind, crossover study | |
| SALARPOUR et al. | Effectiveness of various medications on post operative pain of vital teeth after root canal therapy | |
| JP2006508993A5 (https=) | ||
| Grabowska et al. | MIV-711, a highly selective cathepsin K inhibitor: safety, pharmacokinetics and pharmacodynamics of multiple oral doses in healthy postmenopausal women | |
| Yanev et al. | Pain in obesity is not obesity and pain | |
| Mareeswari et al. | The myriad presentations of lichen planus | |
| Grisham et al. | Contact hypersensitivity stomatitis in response to Suboxone use: A case report | |
| Conrad et al. | Phase 2b study of inhaled MP-376 (Aeroquin, levofloxacin inhalation solution) in stable cystic fibrosis (CF) patients with chronic Pseudomonas aeruginosa (PA) lung infection | |
| López et al. | Effectiveness and toxicity of cyclophosphamide, etoposide, and prednisone as an outpatient oral chemotherapy regimen in elderly and frail patients with non-Hodgkin lymphoma |